Robert Mah
Inventor
Stats
- 43 US patents issued
- 82 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 43 US Patents Issued
- 82 US Applications Filed
- 359 Total Citation Count
- Jun 23, 2022 Most Recent Filing
- Sep 8, 1995 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
NOVARTIS AG | 1
1 1 11 16 17 9 4 11 1 2 5 6 2 5 | 1997
2000 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 |
HONDA MOTOR CO., LTD. | 1
| 2005
|
NOVARTIS CORPORATION | 1
1 | 1995
1996 |
SPEEDEL EXPERIMENTA AG | 2
2 3 | 2005
2006 2007 |
CIBA-GEIGY CORPORATION | 1
| 1995
|
NOVARTIS PHARMA AG | 2
1 | 2004
2008 |
Inventor Addresses
Address | Duration |
---|---|
Allschwil, CH | Feb 18, 97 - Sep 11, 12 |
Basel, CH | Feb 17, 98 - Nov 07, 24 |
Muenchenstein, CH | Nov 17, 22 - Jul 18, 23 |
Muttenz, CH | Jan 11, 07 - Sep 29, 20 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 3 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 75 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 45 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2024/0366,567 | 2024 | PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND USES THEREOF FOR THE TREATMENT OF CANCERS | 0 |
2024/0317,721 | 2024 | PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN | 0 |
2024/0116,900 | 2024 | NEW CRYSTALLINE FORMS OF A KRAS G12C INHIBITOR COMPOUND | 0 |
2024/0082,218 | 2024 | PHARMACEUTICAL COMBINATIONS COMPRISING A KRAS G12C INHIBITOR AND USES OF A KRAS G12C INHIBITOR FOR THE TREATMENT OF CANCERS | 0 |
11702409 | 2023 | Pyrazolyl derivatives useful as anti-cancer agents | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.